BioSpace News Archive

Business

Bio-herbMD Promotes National Nutrition Month in March

National Nutrition Month is underway, and Bio-herbMD wants everyone to take stock of their eating habits and the importance of a proper diet.

March 25, 2019
·
2 min read
Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research

Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the clinical development of drugs to treat neurodegenerative diseases

March 25, 2019
·
4 min read
AlzeCure to Present at International Scientific Conference

AlzeCure Pharma AB announced that it will have two presentations at AD/PD 2019, the 14th International Conference on Alzheimer’s & Parkinson’s Diseases, March 26-31, in Lisbon, Portugal.

March 25, 2019
·
2 min read
Business

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.

March 25, 2019
·
3 min read
Genetown

CutisPharma Announces Launch of FIRST®-Atenolol Unit-of-Use Prescription Compounding Kit for Oral Solution

CutisPharma, Inc. announced today the commercial availability of FIRST-Atenolol grape-flavored oral solution compounding kit.

March 25, 2019
·
1 min read
Deals

Prometic secures additional USD $5 million (CAD $6.7 million) tranche from structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities

Prometic Life Sciences Inc. announced that it has secured an additional USD $5 million tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under the existing loan agreement originally entered into with SALP in November 2017.

March 25, 2019
·
4 min read
Genetown

Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients

Greatest ppFEV1 Improvement Shown in High Dose Triplet with Mean Absolute Improvement in ppFEV1 of 8 Percentage Points at 14 Days Compared to Placebo (p<0.05) in Subjects with Two F508del Mutations (F/F) Not Predisposed to Rapid Pulmonary Decline

March 25, 2019
·
11 min read
Genetown

Phio Pharmaceuticals to Present Poster on the Use of Self-Delivering RNAi in Immuno-oncology at the AACR Annual Meeting 2019

Phio Pharmaceuticals Corp. announced that the Company will present a poster at the American Association for Cancer Research Annual Meeting 2019, which will be held from March 29–April 1, 2019 at the Georgia World Congress Center in Atlanta, Georgia.

March 25, 2019
·
3 min read
IMV Inc. to Present at Two Upcoming Investor Conferences

IMV Inc., a clinical stage immuno-oncology company, announced that IMV Chief Executive Officer Frederic Ors will present at the Spring Investor Summit and the HC Wainwright Global Life Sciences Conference during April 2019.

March 25, 2019
·
1 min read
Deals

AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update

Introduced plato™ platform for worldwide gene therapy commercialization, to be incorporated in AVROBIO-sponsored clinical trials in 2019

March 25, 2019
·
13 min read